L-745870
CAS: 158985-00-3
Ref. 3D-IGA98500
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Informação sobre produto
- 1H-Pyrrolo[2,3-b]pyridine, 3-[[4-(4-chlorophenyl)-1-piperazinyl]methyl]-
- 3-(4-[4-Chlorophenyl]Piperazin-1-Yl)-Methyl-1H-Pyrrolo[2,3-B]Pyridine Trihydrochloride
- 3-[[4-(4-Chlorophenyl)-1-piperazinyl]methyl]-1H-pyrrolo[2,3-b]pyridine
- 3HCl
- L 745870
L-745870 is a drug that has been shown to have an inhibitory effect on monoamine neurotransmitter levels. It is currently being investigated as a potential treatment for symptoms of Parkinson's disease. L-745870 binds to the oxytocin receptor and inhibits serine protease activity, thereby reducing the production of dopamine and other monoamines. In humans, L-745870 has been shown to increase locomotor activity in doses that do not cause any adverse side effects. The effective dose for L-745870 is 10 mg/kg, and it reaches its maximal response at 60 minutes after administration. This drug also has an excellent profile with regard to pharmacokinetics and safety.
Propriedades químicas
Consulta técnica sobre: 3D-IGA98500 L-745870
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
